AET - Aetna Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
0.0000
0.0000 (0.33%)
At close: 4:02PM EST
Stock chart is not supported by your current browser
Previous Close0.0000
Open212.5700
Bid0.00 x 800
Ask0.00 x 800
Day's Range211.7900 - 213.3600
52 Week Range166.8900 - 213.3600
Volume10,740,557
Avg. Volume2,795,549
Market Cap0
Beta (3Y Monthly)0.89
PE Ratio (TTM)0.00
EPS (TTM)11.12
Earnings DateJan 28, 2019 - Feb 1, 2019
Forward Dividend & Yield2.00 (0.97%)
Ex-Dividend Date2018-10-23
1y Target Est208.31
Trade prices are not sourced from all markets
  • The Wall Street Journal4 hours ago

    [$$]

    Apple Inc. unveiled its biggest and most expensive iPhone lineup ever, but later reports of the company cutting supply orders raised questions about how well the models were connecting with consumers. Comcast Corp., though, later beat out Disney and Fox by agreeing to pay $38.8 billion for European pay-TV giant Sky PLC. AT&T Inc. was allowed to proceed with its $80 billion acquisition of Time Warner Inc., after a federal judge ruled the Justice Department hadn?t proved its case that the deal would suppress competition in the pay-TV industry.

  • The Wall Street Journal4 hours ago

    [$$] CVS Urges Judge Not to Halt Integration of Aetna

    WASHINGTON—A federal judge on Tuesday softened his previous suggestion that he would likely order CVS Health Corp. to halt its integration of newly acquired insurer Aetna Inc. U.S. District Judge Richard Leon in recent weeks has voiced concerns about the companies’ settlement with Justice Department antitrust enforcers that allowed the nearly $70 billion deal to proceed. The judge, who must decide whether to approve the settlement, earlier this month raised the prospect of requiring CVS, a pharmacy-benefit manager with a network of pharmacies, to hold Aetna’s assets separately for now while he considers in more detail whether the settlement is in the public interest.

  • Judge mulls using monitor to oversee CVS during court process
    Reuters7 hours ago

    Judge mulls using monitor to oversee CVS during court process

    A federal judge said on Tuesday that he was considering using a court-appointed monitor to make sure CVS Health Corp refrains from fully integrating with insurer Aetna while he examines the companies' settlement with the government. Judge Richard Leon of the U.S. District Court for the District of Columbia held the hearing as part of his review of the antitrust settlement reached with the Justice Department to win approval for the companies' $69 billion merger. The Justice Department approved the merger of CVS, a U.S. pharmacy chain and benefits manager, and Aetna in October on condition that Aetna sell its Medicare prescription drug plan business to WellCare Health Plans Inc .

  • Judge mulls using monitor to oversee CVS during court process
    Reuters7 hours ago

    Judge mulls using monitor to oversee CVS during court process

    A federal judge said on Tuesday that he was considering using a court-appointed monitor to make sure CVS Health Corp refrains from fully integrating with insurer Aetna while he examines the companies' settlement with the government. Judge Richard Leon of the U.S. District Court for the District of Columbia held the hearing as part of his review of the antitrust settlement reached with the Justice Department to win approval for the companies' $69 billion merger. The Justice Department approved the merger of CVS, a U.S. pharmacy chain and benefits manager, and Aetna in October on condition that Aetna sell its Medicare prescription drug plan business to WellCare Health Plans Inc (WCG.N).

  • Motley Fool14 hours ago

    Healthcare: Deals, Deals, and More Deals in 2018

    Highlighting some of the most important healthcare mergers and acquisitions of this year.

  • Pass it on: CVS CEO says the learning should never stop
    Associated Press3 days ago

    Pass it on: CVS CEO says the learning should never stop

    Larry Merlo has learned a few things during nearly eight years as CEO of one of the nation's biggest drugstore chains — including that you shouldn't ever stop learning. CVS Health Corp. is polishing off a $69-billion acquisition of the health insurer Aetna. The company, which also manages pharmacy benefits, is focusing more on providing in-store health care services and telemedicine, as retailers face pressing competition for product sales from the online giant Amazon.com.

  • Insider Q&A: CVS Health CEO seeks bigger role in your care
    Associated Press3 days ago

    Insider Q&A: CVS Health CEO seeks bigger role in your care

    CVS Health CEO Larry Merlo wants customers to think about more than prescriptions and shampoo when they visit his company's drugstores. CVS has largely finished its $69 billion acquisition of the insurer Aetna, part of the company's broader effort to expand its health care offerings. Merlo spoke recently with The Associated Press.

  • Is Walgreens Boots Alliance a Buy?
    Motley Fool3 days ago

    Is Walgreens Boots Alliance a Buy?

    The pharmacy giant has the wind at its back right now. But will the winds change?

  • CVS defends settlement that allowed Aetna merger as judge assesses
    Reuters4 days ago

    CVS defends settlement that allowed Aetna merger as judge assesses

    CVS Health Corp (CVS.N) defended on Friday an agreement with the U.S. Justice Department which allowed it to purchase health insurer Aetna for $69 billion, a settlement that a federal judge is still assessing. The Justice Department approved the merger of CVS, a U.S. pharmacy chain and benefits manager, and Aetna in October on condition that Aetna sell its Medicare prescription drug plan business to WellCare Health Plans Inc (WCG.N). Now, the Justice Department and companies have found themselves in the unusual position of defending their antitrust settlement to a skeptical federal judge.

  • CVS defends settlement that allowed Aetna merger as judge assesses
    Reuters4 days ago

    CVS defends settlement that allowed Aetna merger as judge assesses

    The Justice Department approved the merger of CVS, a U.S. pharmacy chain and benefits manager, and Aetna in October on condition that Aetna sell its Medicare prescription drug plan business to WellCare Health Plans Inc . Now, the Justice Department and companies have found themselves in the unusual position of defending their antitrust settlement to a skeptical federal judge. In its brief, filed on Friday, CVS said that the deal had been extensively reviewed and urged the judge to allow the companies to continue integrating while he examines the settlement reached with the government.

  • Motley Fool4 days ago

    Ask a Fool: What Should I Do if a Company Whose Stock I Own Gets Acquired?

    The right answer depends on the details of the acquisition.

  • CNBC4 days ago

    Goldman downgrades Walgreens' stock to rare 'sell,' shares fall

    Goldman analyst Robert Jones said he doesn't think Walgreens' numerous partnerships with other companies will help offset declines in its core retail pharmacy business. He downgraded Walgreens to "sell" ...

  • CNBC4 days ago

    Goldman downgrades Walgreens' stock to rare 'sell,' shares fall

    Goldman analyst Robert Jones said he doesn't think Walgreens' numerous partnerships with other companies will help offset declines in its core retail pharmacy business. He downgraded Walgreens to "sell" from "hold" Friday.

  • Asian shares fall on poor Chinese economic data
    Associated Press5 days ago

    Asian shares fall on poor Chinese economic data

    SINGAPORE (AP) — Asian markets tumbled on Friday after China reported weaker-than-expected economic data, stirring up worries about the state of the world's second largest economy.

  • Associated Press5 days ago

    CVS and Delta fall while Aflac and General Electric jump

    Stocks that moved substantially or traded heavily Thursday: CVS Health Corp., down $1.13 to $73.37 The New York Post reported that a judge might bar CVS from integrating its business with health insurer ...

  • TheStreet.com5 days ago

    U.S. Stocks Close Mixed After Late Rally; GE, P&G Gain

    The Dow Jones Industrial Average rose Thursday as Wall Street expressed optimism over U.S. and China trade talks. said Thursday it would invest $1 billion to build a new campus in Austin, Texas. Stocks traded mixed on Thursday, Dec. 13, as Wall Street monitored trade developments between the U.S. and China, the world's two largest economies.

  • Motley Fool6 days ago

    Top 10 Healthcare Stories of 2018

    New drugs, trial flops, M&A, and a little bit of everything else that happened in healthcare in 2018.

  • TheStreet.com6 days ago

    Apple, Adobe, Huawei, CVS and Boy Scouts - 5 Things You Must Know

    U.S. stock futures were mixed on Thursday, Dec. 13, and shares in Asia closed higher as trade tensions eased between the U.S. and China, the world's two largest economies. Wall Street finished higher on Wednesday, Dec. 12, as investors cheered progress in U.S.-China trade talks and after a report said China was planning a new program that promised greater access for foreign companies. The Wall Street Journal reported Wednesday that China was drafting a replacement for Made in China 2025 - President Xi's blueprint to make the country a leader in high-tech industries - which would play down China's bid to dominate manufacturing and be more open to participation by foreign companies.

  • CNBC7 days ago

    In acquiring Aetna, CVS embarks on another pivotal moment in its 55-year history

    CVS Health acquired health insurance giant Aetna for about $70 billion. CVS has bought other pharmacies to build its footrprint, as well as pharmacy benefit manager Caremark and walk-in health clinic MinuteClinic. It's buying a health insurer to prove it.

  • TheStreet.com8 days ago

    Expect Less M&A in 2019 as Big Year Comes to a Close

    To start 2018, many on Wall Street were predicting a great year for stocks, as Donald Trump's tax plan was expected to produce elevated mergers and acquisitions activity. The deal activity has certainly been a part of the 2018 story, but the trend could slow down in 2019, said analysts from Goldman Sachs. Deal announcements are expected to increase 20% year over year in 2018, according to a note from Goldman that was released Tuesday.

  • CNBC8 days ago

    Stocks making the biggest moves premarket: DSW, F, GM, CVS, PFE & more

    These are the stocks posting the largest moves before the bell.

  • The Wall Street Journal12 days ago

    [$$] Walgreens Launches Next-Day Prescription Home Delivery With FedEx

    Walgreens Boots Alliance Inc. has teamed up with FedEx Corp. to launch a nationwide next-day prescription home-delivery service as the drugstore chain works to stave off competition from Amazon.com Inc. and other rivals. Under the delivery service called Walgreens Express, patients enrolled in text alerts will receive text notification when qualifying prescriptions are ready, Walgreens said Thursday. For a $4.99 fee, patients can have their prescriptions delivered by FedEx to their home as early as the next day.

  • Walgreens expands prescription delivery program nationwide
    Associated Press13 days ago

    Walgreens expands prescription delivery program nationwide

    Walgreens is joining rival drugstore chain CVS Health in expanding home deliveries for prescriptions nationwide, as stores continue adjusting to a retail world made more consumer-friendly by online competition. Walgreens said Thursday it will partner with FedEx to deliver prescriptions as soon as the next day for a $4.99 fee, and it also is providing same-day deliveries in several cities including New York, Chicago and Dallas. Walgreens and FedEx Corp. began a partnership last year where the drugstore chain started offering package drop-off and pick-up services at several thousand stores.